+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
Hemophilia Treatment - Global Strategic Business Report - Product Thumbnail Image

Hemophilia Treatment - Global Strategic Business Report

  • Report
  • January 2026
  • 476 Pages
  • Global
From
Rare Hemophilia Factors - Global Strategic Business Report - Product Thumbnail Image

Rare Hemophilia Factors - Global Strategic Business Report

  • Report
  • January 2026
  • 132 Pages
  • Global
From
Needle-Free Devices: Technologies and Global Markets - Product Thumbnail Image

Needle-Free Devices: Technologies and Global Markets

  • Report
  • June 2025
  • 156 Pages
  • Global
From
From
From
Clobetasol Propionate API Market - Global Forecast to 2030 - Product Thumbnail Image

Clobetasol Propionate API Market - Global Forecast to 2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
Diabetes Management Devices Market 2024-2028 - Product Thumbnail Image

Diabetes Management Devices Market 2024-2028

  • Report
  • January 2024
  • 163 Pages
  • Global
From
Anti-obesity Drug Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Anti-obesity Drug Market Forecasts from 2023 to 2028

  • Report
  • October 2023
  • 140 Pages
  • Global
From
From
Loading Indicator